GRACE HARRIS: Open Payments
NPI 1750082012 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,714 in 163 payments from 18 companies in 2025. Trend: 2023 $1,345 · 2024 $2,004 · 2025 $2,714
Food & beverage: $2,714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $776 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $269 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $242 |
| Madrigal Pharmaceuticals | 7 | $165 |
| Aimmune Therapeutics, Inc. | 10 | $153 |
| Ardelyx, Inc. | 10 | $138 |
| Phathom Pharmaceuticals, Inc. | 14 | $138 |
| Janssen Biotech, Inc. | 7 | $137 |
| GENZYME CORPORATION | 6 | $122 |
| QOL Medical, LLC | 5 | $117 |
Products named: RINVOQ, ENTYVIO, XIFAXAN, DUPIXENT, REZDIFFRA, ZENPEP, IBSRELA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
